Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $7.69 Million - $9.73 Million
71,600 Added 10.19%
774,400 $105 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $3.73 Million - $4.24 Million
-35,100 Reduced 4.76%
702,800 $75.8 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $29.5 Million - $32.9 Million
-280,500 Reduced 27.54%
737,900 $82.9 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $5.14 Million - $5.65 Million
-50,200 Reduced 4.7%
1,018,400 $110 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $6.1 Million - $8.24 Million
-75,800 Reduced 6.62%
1,068,600 $115 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $45.7 Million - $53.6 Million
531,900 Added 86.84%
1,144,400 $100 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $6.12 Million - $8.19 Million
-83,400 Reduced 11.98%
612,500 $60.1 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $5.81 Million - $8.81 Million
-90,100 Reduced 11.46%
695,900 $53 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $12.1 Million - $15.1 Million
167,200 Added 27.02%
786,000 $69.6 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $327,496 - $393,744
5,200 Added 0.85%
618,800 $46.9 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $9.59 Million - $12.3 Million
146,000 Added 31.22%
613,600 $44.6 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $34.9 Million - $41.1 Million
452,900 Added 3080.95%
467,600 $37.7 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $233,549 - $288,030
3,000 Added 25.64%
14,700 $1.36 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $3.44 Million - $4.07 Million
-38,300 Reduced 76.6%
11,700 $1.08 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $4.48 Million - $4.91 Million
-50,000 Reduced 50.0%
50,000 $4.84 Million
Q2 2017

Aug 14, 2017

BUY
N/A
100,000
100,000 $7.25 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.